Certain Balance Sheet Information

Cash and Cash Equivalents

Cash and cash equivalents were $38.6 million as of June 30, 2016 for the Successor and $127.7 million as of September 30, 2015 for the Predecessor. These amounts included the following:



	Successor		Predecessor
	June 30, 2016		September 30, 2015
Cash held by foreign subsidiaries	$	35.4	$	54.1
Non-U.S. dollar denominated currency held by foreign subsidiaries	$	33.0	$	45.0
Currency denominated in RMB	$	8.9	$	4.7

Non-U.S. dollar denominated currency held by foreign subsidiaries was primarily in euros and RMB. While the RMB is convertible into U.S. dollars, foreign exchange transactions are subject to approvals from SAFE. The Company does not anticipate any significant adverse impact to overall liquidity from restrictions on cash and cash equivalents.

Inventories

Inventories at June 30, 2016 and September 30, 2015 consisted of the following:



	Successor		Predecessor
	June 30, 2016		September 30, 2015
Finished products	$	317.2	$	320.9
Supplies	4.3		4.2
Total	$	321.5	$	325.1

The Company’s inventories in the U.S. and Canada are collateral under the New Credit Facilities.

Other Non-Current Assets

Other non-current assets at June 30, 2016 and September 30, 2015 consisted of the following:



	Successor		Predecessor
	June 30, 2016		September 30, 2015
Debt issuance costs of revolving credit facilities	$	6.7	$	5.4
Other	3.2		3.4
Total	$	9.9	$	8.8

In connection with the New Credit Facilities, the Company incurred debt issuance costs of $25.3 million during the nine months ended June 30, 2016. Of these, $6.8 million related to the New ABL Facility and were recorded in Other non-current assets on the condensed consolidated balance sheet. The remaining $18.5 million of debt issuance costs related to the New Term Loan Facility and were recorded as a reduction of the debt. See Note 7.

Amortization of debt issuance costs related to the New ABL Facility recorded in Interest expense in the condensed consolidated income statements was $0.1 million for the three and nine months ended June 30, 2016 for the Successor.

In connection with the Business Combination, debt issuance costs totaling $9.3 million, associated with the Predecessor were derecognized as part of the purchase consideration allocation. Amortization of debt issuance costs related to the Predecessor ABL Facility recorded in interest expense were $0.6 million and $2.1 million for the periods April 1, 2016 through June 8, 2016 and from October 1, 2015 through June 8, 2016 for the Predecessor, respectively, and $0.8 million and $2.3 million for the three and nine months ended June 30, 2015 for the Predecessor, respectively.

Investments and Cash Previously Held in Trust

Prior to the Business Combination, the Company held in a trust account securities which the Company had the ability and intent to hold until maturity. Held-to-maturity treasury securities were recorded at amortized cost and adjusted for the amortization of the original discount. During the nine months ended June 30, 2016, the Company recognized $0.6 million of amortization related to the original discount, which was recorded in Interest income in the condensed consolidated income statement. As part of the Business Combination, the Company withdrew all proceeds from the trust account.